Hypertension Management in ESRD Patients

Introduction to Alternative Antihypertensive Agents

The American Heart Association recommends that for an ESRD patient allergic to hydralazine, minoxidil is the most appropriate alternative vasodilator for resistant hypertension, but it must be combined with a beta-blocker and loop diuretic to counteract reflex tachycardia and profound sodium retention 1, 2

The American College of Cardiology suggests that volume management is the cornerstone of hypertension control in ESRD through ultrafiltration and dietary sodium restriction (<2400 mg/day) 1
The American Heart Association recommends loop diuretics (not thiazides) for volume control in ESRD patients, though they are less effective for BP lowering than in patients with preserved renal function 3
The American College of Cardiology suggests that ACE inhibitors or ARBs are reasonable first-line agents that provide cardioprotective effects independent of BP reduction, though hyperkalemia risk requires close monitoring 3
The American Heart Association recommends beta-blockers (carvedilol, metoprolol succinate, bisoprolol) to decrease mortality and improve left ventricular function in ESRD patients 3

The American College of Cardiology recommends minoxidil as an alternative vasodilator, starting at 2.5 mg two to three times daily and titrating upward, with a critical requirement of concurrent beta-blocker and loop diuretic therapy 1, 2, 4
The American Heart Association suggests that minoxidil is a very potent vasodilator generally reserved for severe hypertension in dialysis patients and lowers BP effectively in most cases 4

The American College of Cardiology recommends mineralocorticoid receptor antagonists (spironolactone or eplerenone) as Step 3, though use extreme caution if eGFR <30 mL/min and monitor potassium closely 1, 3
The American Heart Association suggests beta-blockers or combined alpha-beta blockers (labetalol, carvedilol) if heart rate >70 bpm 1, 2

The American College of Cardiology recommends avoiding nondihydropyridine calcium channel blockers (verapamil, diltiazem) in heart failure with reduced ejection fraction 3, 5
The American Heart Association suggests avoiding alpha-blockers (doxazosin) unless other drugs at maximum tolerated doses are inadequate 3
The American College of Cardiology recommends avoiding hydralazine without nitrates, which causes harm in heart failure with reduced ejection fraction (Class III) 3, 6